Concurrent Chemoradiotherapy Containing Paclitaxel and Cisplatin With/Without Tarceva in Locally Advanced Esophageal Carcinoma: a Randomized Phase III Multi-center Trial.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Erlotinib (Primary) ; Cisplatin; Paclitaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 07 Jun 2016 Two year results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 27 Nov 2013 Planned end date changed from 1 Mar 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 27 Nov 2013 Planned number of patients changed from 325 to 512 as reported by ClinicalTrials.gov.